Study Compares Skull Acoustic Models for Transcranial Ultrasound Therapy Simulation
A cross-comparison study tested five computational skull models used in transcranial focused ultrasound (tFUS) simulations, finding mean peak-pressure errors of 20–31% and intensity errors of 41–77% across all models. The research evaluated models against physical hydrophone measurements across seven human skulls at three ultrasound frequencies. The findings raise concerns about the quantitative reliability of current simulation-guided tFUS, which is used in clinical and research settings to non-invasively target brain tissue.
Researchers experimentally validated five skull acoustic modelling strategies used in transcranial focused ultrasound (tFUS) simulations, a technique that non-invasively delivers ultrasound energy to specific brain targets for therapeutic purposes. Using acoustic holography to reconstruct source fields and needle-hydrophone measurements as ground truth, the study benchmarked simulated intracranial pressure fields across 19 regions of interest from seven human skulls at 220 kHz, 680 kHz, and 1000 kHz. Mean peak-pressure errors ranged from 20% to 31%, intensity errors from 41% to 77%, and focal volume errors from 11% to 67%, with focal position discrepancies of several millimetres. Critically, all models tended to underestimate skull-related attenuation, meaning they systematically overestimate how much ultrasound energy actually reaches the brain. The linear mapping model with fixed attenuation performed best on average pressure error, but no single model outperformed the others consistently across all metrics. The authors conclude that while current models can reproduce gross beam patterns, substantial quantitative uncertainty remains in exposure levels, focal coverage, and target localisation — all clinically relevant parameters.
What's missing
The study uses Thiel-embalmed and historical cadaveric skulls, which may have different acoustic properties than living human skulls with perfused tissue; the authors do not fully characterise how embalming affects the generalisability of results to in vivo clinical scenarios. Additionally, the study does not assess whether the observed errors translate into clinically meaningful differences in treatment outcomes, leaving the practical safety and efficacy implications unquantified.
What different sources said
- arXiv physicsCenter
Spatially heterogeneous power-law attenuation with multiple relaxation mechanisms for ultrasound modeling
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.